Background Sublingual immunotherapy (SLIT) is an effective secondary prevention to improve natural course of asthma. Its efficacy is limited to allergic asthma caused by inhalant allergen. Recent studies showed that probiotic as immunomodulator decreases inflammatory process induced by food allergy. No suf ficient clinical evidence reported about the efficacy of combination sublingual immunotherapy and probiotics or probiotics only in clinical improvement of childhood asthma. Objective To investigate the role of SLIT and probiotic on clinical parameters of childhood asthma (FEV1 reversibility, medication score, and symptom score). Methods A randomized single blind clinical trial was conducted
S
ublingual immunotherapy (SLIT) is very effective in the management of asthma in children sensitive to inhalant allergen. The efficacy of SLIT in allergic asthma due to food allergy is not yet proven. 1 proving microbial balance, may mediate antiallergenic , and gut sIgA. of allergy in children, but until recently few clinical tri als exist. Observational studies in humans also support the importance of the intestinal microbiota in immune development, and have found a relationship with the development of hypersensitivity. Interestingly these differences in load and species composition of Bifidobacteria have not been found in young children with wheeze and allergic sensitization. 3, 4 It is expected that probiotic may act synergistically to improve the clinical efficacy The purpose of this study was to investigate the role of SLIT and probiotic on clinical parameters of childhood asthma (FEV 1 reversibility, medication score and symptom score).
Methods Patients
Asthmatic children treated at Allergy and Immunology enrolled in this study. A written informed consent form receiving information of the study.
Inclusion criteria of subjects were either gender, 1 > predicted normal value at Visit 1 whereas subjects who lator FEV1 > normal value at Visit 1. For those subjects with an if they had an absolute FEV 1 /FVC ratio measured on > given immediately proceeding Visit 1. asthma including severe asthma, any prior intubations, respiratory arrest or seizures within the past 5 years as Visit 1 or any visit to emergency room due to asthma fiers, inhaled long acting agonist, oral to meet the concomitant medication restrictions.
Subjects would be withdrawn if they had: intoler able adverse event, decreased FEV 1 > albuterol or salbutamol pMDI/ day for two days within baseline (baseline defined as the mean value of the last The study was designed as true experimental blind trial. The patients were enrolled in three groups:
incorporating a random number generator data.
Sublingual immunotherapy (SLIT)
immunotherapy. The composition of the allergens oral was dilution of strength 1. Initial treatment set: 3 vials each. Treatment begun with 1 drop of the weakest concentration (strength 1). This dose was increased was again increased by 1 drop daily until the dose increased daily by 1 drop until the maximum dose of
Probiotics preparation
Each capsule contained: L. johnsonii, L. paracasei, and B. lactis 9 each strain was given twice daily. During the 14 week study period, the patients were asked to be abstain from any fermented food products containing live microorganisms.
Symptom scores and medication score
Subjects recorded their daytime asthma symptoms score according to the following scale: require medication.
were not bad enough to cause trouble with daily routine activities. Did not require albuterol.
which caused some interference with daily routines activities. Required albuterol.
tinuously or present most of the day which severely restricted daily routine activities. Airway reversibility was tested using spirometry before and after administration of inhaled albuterol after albuterol administration. An improvement of > of reversible airway obstruction. 
Treatment protocol

Visiting procedure:
Visit I All subjects were asked to get certain information and to undergo tests and procedures as indicated below:
clinical history of asthma.
test of FEV 1 .
The subject/guardian will be instructed to record diary information on a daily basis.
Visit II to Visit XIII
garding concomitant medications and adverse events.
ibility.
related procedures and wish to continue, they were then randomized, and were asked to col lect and dispense study drug, and were informed regarding the dosing regimen.
Visit XIV
and throat examination.
query.
ibility).
receive other appropriate asthma treatment at the discretion of the investigators.
Statistical analysis
of significance. The analysis for all data was performed as means (SD) unless otherwise noted. Differences between the groups were tested for significance with between group were analyzed using Anova, Chi square, and Mann Whitney test. Differences of symptom and medication score between groups were analyzed using Wilcoxon signed ranks test.
outcomes were symptom score and medication score.
Results
A total of 34 children with bronchial asthma with the onset less than two years treated in our institution during the study period were included in this study. Of these, 11 patients were treated by SLIT (Group (Group B), and 11 patients by probiotics only (Group C). Two patients were dropped out from the study in good condition because their families moved to other city. There were no significant differences in age, gender, body weight, height, and history of atopy between the groups (Table 1 ). All groups started with the homogenious performance. There was no adverse event at all groups.
ing FEV1 reversibility that reflected bronchial hyper reactivity (Table 2 ).
The value of FEV1 reversibility in groups A,
respectively. There was significant differences of FE V 1 The symptom score was also improved signifi cantly in all groups (Table 3 ).
The symptom score in group, group B and group C no significant difference of symptom score between
The medication score was also improved signifi cantly in all groups (Table 4 ). The medication score in group A, group B and group C decreased from
Discussion
There has been some published evidence that gender, age, body weight, and height influence the result of lung function test. 5 The results of our study indicated that there were no significant differences between the groups.
Lung function test was performed in accordance with standardized guidelines. Lung function test with spirometer can be done in a cooperative child to es tablish the diagnosis accurately, even in mild asthma. Forced Expiratory Volume in One Second (FEV 1 ) is the amount of air that is forcefully exhaled in the first second of the FVC test. In general, it is common that their vital capacity in the first second of the FVC test.
1 has a pulmonary function value that is highly diagnostic in obstructive disease, but FEV 1 only cannot be used to diagnose obstructive and restrictive disorders all by itself. If the patient demonstrates a reduced FEV 1 , the patient may repeat the test after inhaling a bronchodilator. Bronchodilator dilates the bronchial passages and reduces airflow obstruction.
FEV 1 improvement. This simple clinical test of FEV 1 reversibility, strongly suggests that the low FEV1 is due to obstructive phenomenon. If FEV 1 does not change, it suggests that the low FVC is possibly low due to restrictive pathologies. It is expressed as liters. FEV 1 reversibility is accounted from the following formula:
It is a sensitive parameter to estimate the extent of airflow obstruction and to monitor the result of therapy. This variable showed a progressive result in both intervention. 5 FEV 1 reversibility in this study decreased sig nificantly. The most marked decrease of FEV 1 revers ibility and symptom score were found in SLIT group. Decreased FEV 1 in this group was similar with that of the study by Bosquet et al in 85 children with asthma given SLIT every day for 4 weeks, continued three The similar significant decrease in FEV 1 reversibility in groups of probiotics only and combination of SLIT and probiotics shown in this study had not been noticed in other studies. Therefore this study gave new information that a combination of SLIT and probiotics was also able to improve clinical outcomes in childhood asthma.
The reduction of asthma symptoms (asthma score and medication score) were closely related to the reduction of the degree of bronchoconstriction. tion test. The recommendations of the National test is essential in the diagnosis and management of asthma because of evidence that both patients and physicians have inaccurate perceptions of the severity of asthma that contribute to delays in treatment. Indeed, underestimation of the extent of airflow (airway) obstruction is associated with identify obstructive or restrictive patterns reliably from history taking and physical examination only. Lung function test can be used to predict the pos sibility of the presence of obstructive pattern by or restrictive patterns are correct only by about half of the time. Besides identifying abnormalities, lung function tests allow the severity of an abnormal ity to be quantified and the presence of reversible airflow obstruction to be determined.
All groups had significant decrease in symptom decrease of symptom score compared to that of other groups, although statistically insignificant. The similar influences of sublingual immunotherapy on clinical vious studies. All these studies described a decrease in asthma symptom score in patients with sublingual immunotherapy. asthmatic children had never been studied before. A study by Rosenfeldt et al and Viljanen et al 13 in children with atopic dermatitis showed that probiotics was able to decrease clinical symptoms in accordance to SCORAD criteria. Another study by Wang14 in allergic rhinitis patients who were given probiotics (L. paracasei) showed a significant decrease of clinical symptoms.
The potential of mucosal approach via gas trointestinal tract in modulation of broad spectrum systemic hyporesponsiveness has been increasing to modify natural course of allergic disease. 15 Gastro intestinal tract is the largest immunologic organ in the body. It is lined by a single layer of epithelium. It is constantly exposed by large amounts of dietary proteins and other antigens. Despite the large extent of dietary antigenic exposure, only small percentage of individuals has allergic reaction. This is due to de Oral tolerance, refers to a state of active inhibition of immune response to an antigen by means of prior ex pose of that antigen through oral route. Oral delivery is effective in inducing both systemic and generalized mucosal immune responses. This property has been 4 The exact mechanisms of induction of oral tolerance are still under debate. therapy shows evidence of clinical efficacy in the treat ment of respiratory allergies. It has been demonstrated that in atopic patients, the allergen can cross the gastrointestinal mucosa, leading to a desensitization of the immune system. 1 Result of our study indicated clinical improve ment of asthma score, medication score, and lung function test described by FEV 1 reversibility. Statisti cal analysis of efficacy between all groups revealed insignificant differences which meant that sublingual immunotherapy, combination of sublingual immuno therapy and probiotics, or probiotics only had a similar efficacy on the improvement of clinical symptoms of childhood asthma.
Differences in medication score between all Several studies about the efficacy of sublingual immu study by Lilja et al 18 significant decrease in medication score was found in both groups. Another study by Bousquet et al in al lergic asthma children with sublingual immunotherapy revealed insignificant differences between groups in ticosteroid, and systemic corticosteroid).1 Several other found also similar results. Medication and symptom scores are useful clini cal parameters to assess the clinical efficacy of immu notherapy aside from other immunological parameters such as cell markers and cytokine profiles. Assessment of immunotherapy can be done using objective and subjective parameters. Although objective assessment is more preferable, often it is not practical to be used routinely in clinical setting. Therefore, most experts trust subjective assessment by clinicians, including all complaints of patients about their allergy symp toms.
Several studies showed that sublingual immu notherapy and probiotics are able to decrease clini cal symptoms of allergy and asthma.
Incomplete explanations of its mechanism made the decrease was only seen as a subjective parameter. Many research ers had tried to explain the mechanism of decreasing allergy reactions only through total IgE and IgG, whereas IgA is the most important factor due to its as transcriptors for IgA. A study on experimental cosal IgA increased after probiotics administration. These studies consistently showed improvements of allergic clinical symptoms, although no decrease in total IgE was found.
To conclude, our study with small number of participants shows that combination of SLIT and probiotics and probiotics only were similarly effective to improve clinical symptoms of childhood asthma. Further studies, preferably with double blind design are needed to establsh a more definitive conclusion. published.
References
